Detalhe da pesquisa
1.
Tubulo-interstitial inflammation increases the risk of graft loss after the recurrence of IgA nephropathy.
Clin Kidney J
; 17(1): sfad259, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38186867
2.
Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry.
Nefrologia (Engl Ed)
; 43(4): 442-451, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37661514
3.
Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients.
Clin Kidney J
; 15(10): 1847-1855, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36147706
4.
[Management of immunosuppressive therapy in kidney transplant recipients with COVID19. A multicentre national study derived form the S.E.N. COVID registry.] / Manejo de la inmunosupresión en pacientes trasplantados de riñón con COVID19. Estudio multicéntrico nacional derivado del registro COVID de la S.E.N.
Nefrologia
; 2022 Apr 30.
Artigo
em Espanhol
| MEDLINE | ID: mdl-35528867
5.
Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
Transplantation
; 106(7): 1430-1439, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384924